Amphipathic chitosans improve the physicochemical properties of siRNA-chitosan nanoparticles at physiological conditions

Carbohydr Polym. 2019 Jul 15:216:332-342. doi: 10.1016/j.carbpol.2019.03.098. Epub 2019 Mar 28.

Abstract

Chitosan has received a lot of attention as a carrier for small interfering RNA (siRNA), due to its capacity for complexation and intracellular release of these molecules. However, one of its limitations is its insolubility at neutral pH and the tendency towards aggregation of its nanoparticles in isotonic ionic strength. In this study, a series of amphipathic chitosans were synthesized by varying the degree of acetylation (DA) from ˜2 to ˜30 mol% and the degree of substitution (DS) from 5 to 25%. by tertiary amino groups (DEAE) The results showed that the adjustment of these parameters decreases the interparticle interactions mediated by hydrogen bonding to obtain nanoparticles with improved colloidal stability. siRNA-containing nanoparticles of 100 to 150 nm with low polydispersities (0.15-0.2) and slightly positive zeta potentials (˜+ 5 mV) were resistant to aggregation at pH 7.4 and ionic strength of 150 mM. This resistance to aggregation is provided by changes on the nanoparticle surface and highlights the importance of more organized self-assembly in providing colloidal stability at physiological conditions. Additionally, the PEGylation of the most promising vectors conferred favorable physicochemical properties to nanoparticles. The chitosans and their nanoparticles exhibited low toxicity and an efficient cell uptake, as probed by confocal microscopy of rhodamine labeled vectors. The results provide a new approach to overcome the limited stability of chitosan nanoparticles at physiological conditions and show the potential of these amphipathic chitosans as siRNA carriers.

Keywords: Amphipathic; Chitosan; Colloidal stability; Nanoparticles; Physiological conditions; siRNA.

MeSH terms

  • Acetic Anhydrides / chemistry
  • Acetylation
  • Animals
  • Chitosan / analogs & derivatives*
  • Chitosan / chemical synthesis
  • Chitosan / metabolism
  • Chitosan / toxicity
  • Diethylamines / chemistry
  • Drug Carriers / chemical synthesis
  • Drug Carriers / chemistry*
  • Drug Carriers / metabolism
  • Drug Carriers / toxicity
  • Fluorescence
  • Fluorescent Dyes / chemistry
  • Hydrogen-Ion Concentration
  • Mice
  • Nanoparticles / chemistry*
  • Nanoparticles / metabolism
  • Nanoparticles / toxicity
  • Particle Size
  • Polyethylene Glycols / chemical synthesis
  • Polyethylene Glycols / chemistry
  • Polyethylene Glycols / metabolism
  • Polyethylene Glycols / toxicity
  • RAW 264.7 Cells
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / chemistry
  • Rhodamines / chemistry
  • Surface-Active Agents / chemical synthesis
  • Surface-Active Agents / chemistry*
  • Surface-Active Agents / metabolism
  • Surface-Active Agents / toxicity

Substances

  • Acetic Anhydrides
  • Diethylamines
  • Drug Carriers
  • Fluorescent Dyes
  • RNA, Small Interfering
  • Rhodamines
  • Surface-Active Agents
  • N,N-diethyl-2-chloroethylamine
  • acetic anhydride
  • Polyethylene Glycols
  • Chitosan